GLI2 expression levels in radical nephrectomy specimens as a predictor of disease progression in patients with metastatic clear cell renal cell carcinoma following treatment with sunitinib.

about

Targeting of miR-150 on Gli1 gene to inhibit proliferation and cell cycle of esophageal carcinoma EC9706.Role of GLI Transcription Factors in Pathogenesis and Their Potential as New Therapeutic Targets

P2860

Q52747348-517885F1-C9D3-4477-8364-2D88E6A66B12 Q58692807-37707486-E158-49B5-976E-8B52E7EAC62C

P2860

GLI2 expression levels in radical nephrectomy specimens as a predictor of disease progression in patients with metastatic clear cell renal cell carcinoma following treatment with sunitinib.

Item

http://www.wikidata.org/entity/Q38747792

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

GLI2 expression levels in radi ...... wing treatment with sunitinib.

@en

type

Item

label

GLI2 expression levels in radi ...... wing treatment with sunitinib.

@en

prefLabel

GLI2 expression levels in radi ...... wing treatment with sunitinib.

@en

P1476

GLI2 expression levels in radi ...... wing treatment with sunitinib.

@en

P2093

Hideaki Miyake

http://www.w3.org/2001/XMLSchema#string

Junya Furukawa

http://www.w3.org/2001/XMLSchema#string

Masato Fujisawa

http://www.w3.org/2001/XMLSchema#string

P2860

TGF-β/SMAD/GLI2 signaling axis in cancer progression and metastasis

Sunitinib in solid tumors

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.

Assessment of efficacy, safety and quality of life of 110 patients treated with sunitinib as first-line therapy for metastatic renal cell carcinoma: experience in real-world clinical practice in Japan.

Sunitinib treatment for patients with clear-cell metastatic renal cell carcinoma: clinical outcomes and plasma angiogenesis markers

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study.

The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth.

Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study

Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells

P304

186-192

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2016.950

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27602218

http://www.w3.org/2001/XMLSchema#string

P932

4998152

http://www.w3.org/2001/XMLSchema#string

GLI2 expression levels in radical nephrectomy specimens as a predictor of disease progression in patients with metastatic clear cell renal cell carcinoma following treatment with sunitinib.

about

P2860

P2860

GLI2 expression levels in radical nephrectomy specimens as a predictor of disease progression in patients with metastatic clear cell renal cell carcinoma following treatment with sunitinib.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932